Gitelman syndrome is a hereditary autosomal recessive kidney disease that affects the reabsorption of charged ions. It is often referred to as familial hypokalemia hypomagnesemia. Protons, positive charges, and electrons, negative charges, are found in unequal amounts in charged ions. Electrolytes such as potassium (K+), sodium (Na+), calcium (Ca+2), and magnesium (Mg+2) are examples of charged ions. To keep electrolyte concentrations in check, charged ions must be secreted and reabsorbed by the kidney's tubules. The distal convoluted tubule's thiazide-sensitive sodium chloride cotransporter is impacted by Gitelman syndrome. About 5% of NaCl, is reabsorbed by the distal convoluted tubule. The body absorbs less salt and chloride as a result of this cotransporter deficiency. Further electrolyte abnormalities, such as excessive bicarbonate levels (metabolic alkalosis), low potassium (hypokalemia), low magnesium (hypomagnesemia), and elevated calcium (hypercalcemia), are also caused by the disruption of other transporters.¹

Introduction to exercise intolerance 

The diminished capacity to engage in physical activity is known as exercise intolerance. The various components of your body must cooperate for you to move. Exercise intolerance may result from issues with the many body systems which are involved in movement. These comprise problems with your muscles, lungs, or heart.

Your symptoms may prevent you from reaching the maximum heart rate for your age. Your body may only be able to absorb and utilize 60% to 70% of the oxygen that an individual without the disease can, during physical exercise. If your heart isn't functioning properly, as in the case of heart failure, this can occur. 

The blood your heart pumps supplies your body's tissues and cells with oxygen. Your heart finds it difficult to circulate blood throughout your body if it is not functioning properly. It may be difficult for people with lung conditions to breathe in enough oxygen to meet their muscles' needs. Your muscles require more oxygen while you exercise than when they are at rest.

Your cells need to use the oxygen that your heart pumps into your body through blood when you breathe it in. Your skeletal muscles cannot effectively consume that oxygen if they are not functioning properly. Exercise intolerance results from an issue with any of these processes (absorbing, distributing, or using oxygen).²

Pathophysiology of Gitelman Syndrome

In the thiazide-sensitive regions of the distal convoluted tubule, a mutation in the genes encoding the human sodium chloride cotransporters and magnesium channels results in Giltelman syndrome (GS), a recessive salt-losing tubulopathy that affects children and young adults. Hypokalemia, hypomagnesemia, hypocalciuria, metabolic alkalosis, and hyperaldosteronism are the features that define the plasma biochemical picture. Patients with GS do, however, exhibit certain clinical and biochemical changes that are similar to those seen in the overuse of thiazide diuretics. From a pathophysiological perspective, GS is a valuable and captivating human model that helps comprehend the clinical outcomes of plasma hydro-electrolytes and acid-base disturbances linked to various hormonal changes. This complicated condition has a negative impact on the patient's quality of life and affects cardiovascular, musculoskeletal, and other physiological functions. This review aims to provide a more concise explanation of the relationship between neurohormonal disorders, electrolytes, and clinical picture. Also, it covers how to differentiate GS from other comparable electrolyte-induced clinical illnesses. ³

Diagnosis

Blood tests to measure serum electrolyte levels, specifically low serum concentrations of magnesium and potassium and/or increased serum concentrations of renin and aldosterone, are laboratory tests used to diagnose Gitelman syndrome. When hypokalemia is present, urine electrolyte testing aims to identify the existence of abnormally elevated potassium levels in the urine. Always suspect GI losses from vomiting and/or diarrhoea when you see low urine chloride levels. Low calcium levels in the urine are similar to a Gitelman syndrome diagnosis. Primary hyperaldosteronism, not Gitelman or Bartter syndromes, should always be suspected when hypertension occurs in a hypokalemic patient who is not on diuretics.

Gitelman syndrome can be diagnosed and confirmed using molecular genetic testing. Genetic testing is only offered as a diagnostic service at specialized laboratories, but it can identify mutations in the particular genes known to cause the condition. To make an accurate diagnosis, genetic testing is typically not required.⁴

Evaluating exercise intolerance

A healthcare provider can use the following tests to identify exercise intolerance:

1. Walk for six minutes: This is walking at a normal pace for six minutes to see how far you can cover
2. Test your stress with exercise: This test monitors your oxygen levels, heart rate, rhythm, and blood pressure as you walk or cycle
3. Testing with cardiopulmonary exercise (CPET): This is riding a bike or walking while a caregiver keeps an eye on your breathing, blood pressure, oxygen saturation, and heart rhythm. It offers the most information and is considered the "gold standard" exam. Your breathing depth, rate, and oxygen intake are all tracked by a mask you wear and breathe through⁵

Management and treatment 

The Gitelman condition has no known treatment. For those who are affected, oral potassium and magnesium supplements along with a high-salt diet constitute the cornerstone of treatment. Foods high in potassium, such as dried fruit, are beneficial. Large single dosages of magnesium supplements should be avoided as they cause diarrhoea. It is recommended to take magnesium supplements in small doses, four to six times a day, to prevent diarrhoea caused by magnesium deficiency, which can exacerbate hypokalemia and volume depletion symptoms. It is advised for many people to take magnesium supplements every day for the rest of their lives. In a few instances, intravenous magnesium administration has been used to treat severe muscle cramps. Generally speaking, reduction of symptoms rather than normalization of electrolyte imbalances should always be the aim of therapy.⁵

Exercise recommendations

The best treatment for exercise intolerance for many people is a physical activity regimen (exercise training). Engaging in moderate-intense physical activity for up to an hour, three times a week, is known as exercise training.

A healthcare physician might create a personalized workout regimen for you. They might take into account your health and the reason behind your exercise intolerance.

Additional therapies for intolerance to exercise could be:

1. Reducing body weight
2. Consuming a diet higher in protein or vitamin D to make up for a deficit, or eating better
3. Treating medical disorders that lead to exercise intolerance with medication or surgery
4. Getting oxygen treatment
5. Engaging in respiratory rehabilitation⁵

Case studies/patient perspectives

Young adults with normal growth who have weakness and cramping in their muscles together with a slight to severe decline in their daily work activities are frequently diagnosed with GS. Vascular hypotension affects a large number of patients. Nonetheless, there are significant differences in each patient's symptom intensity. While some people exhibit minor weakness or are asymptomatic, others have severe neuromuscular symptoms, including cramping, paresthesias, tetany, or paralysis. According to epidemiological research, hypokalemic paralysis affects approximately 6% of GS patients; Asian individuals are more likely to experience this symptom. While some patients complain of constipation, polyuria, and nocturia, others may experience episodes of joint discomfort.

According to a questionnaire, the main symptom affecting 3/4 of GS patients was increased thirst with abnormal water appetite accompanied by a salt craving. The symptoms started in childhood and continued throughout adulthood. Many GS patients were also excited about pickle brine, salted cucumbers, oranges, and lemons in addition to their salt cravings. There have also been documented cases of nephrocalcinosis and chondrocalcinosis.

Increased excretion of magnesium and potassium in the urine, hypocalciuria, hypomagnesemia, hypokalemia, and metabolic alkalosis are the primary electrolyte disorders associated with GS. These hypoglycemia-related symptoms are numerous. On the other hand, not all patients with severe abnormalities of electrolytes also have clinical symptoms. While some patients with mild hypokalemia may exhibit cardiac arrhythmias or paralysis, others with severe hypomagnesemia may not show any symptoms at all.⁶

Future research and perspectives

Hypomagnesemia and hypokalemic alkalosis are linked to disrupted Na+ reabsorption in the distal convoluted tubule (DCT). Gitelman syndrome is characterized by decreased NCC-mediated Na+ reabsorption due to loss-of-function mutations in SLC12A3. Furthermore, because these mutations indirectly lower NCC activity, patients with mutations in CLCKNB, KCNJ10, FXYD2, or HNF1B may have a similar phenotype. Furthermore, pathogenic mutations in MT-TI, MT-TF, KCNJ16, and ATP1A1 have been discovered as a consequence of genetic studies conducted on individuals with Na+-wasting tubulopathy. These discoveries emphasize the significance of basolateral membrane potential and cell metabolism for Na+ reabsorption in the DCT.⁷

Summary

The genetic foundation of GS was discovered thirty years after the condition was initially reported in 1966. The broad range of clinical severity, from incidental identification in essentially asymptomatic people to severe disability in others despite comparable biochemical abnormalities, remains a mystery despite a firm grasp of the underlying renal mechanism. To deliver more effective therapies, a deeper comprehension of the variables contributing to this heterogeneity is essential. There is a strong chance that GS is significantly underdiagnosed, given the large number of incidental diagnoses. At best, there is little support for evidence-based treatment in GS, as is the case with almost all uncommon disorders. The majority of the advice offered in this conference's output is obtained from low-grade evidence since it is based on clinical experience, observational studies, or case reports. We are well aware that these guidelines will change over time. These suggestions, however, are based on our current understanding and provide a foundation for clinical auditing and quality control, against which new treatments can be evaluated.